On June 26, 2024, TrialSpark, Inc. closed the transaction. The company announced that it has issued 45,493,758 series D preferred shares and raised $372,249,945 total gross proceeds in a round of funding co-led by new investors Andreessen Horowitz LLC, and Sanofi. The transaction also included participation from new investors SV Angel Growth I LP, a fund managed by SV Angel, FPV Ventures, LLC, returning investors, Sequoia Capital Operations LLC, Thrive Capital Management, LLC, Emerson Collective, LLC, individual investor, Lachy Groom and other investors.

The transaction included participation from 16 investors pursuant to Regulation D. As part of the transaction, Scott Kupor from Andreessen Horowitz LLC and Alfred Lin from Sequoia Capital Operations LLC will join the company's board of directors. The company has raised funding pursuant to exemption provided under Regulation D.